Kathryn L. Parsley

发表

Development of a clinical trial of gene therapy for X-CGD using the pCCLCHIMGp91WPRE4 lentiviral vector

Christine Kinnon, Aj Thrasher, Michael P. Blundell, 2011 .

Somatic Gene Therapy for X-Linked Severe Combined Immunodeficiency Using a Self-Inactivating Modified Gammaretroviral Vector Results in An Improved Preclinical Safety Profile and Early Clinical Efficacy in a Human Patient

David A. Williams, Kathryn L. Parsley, F. Bushman, 2011 .

Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Kathryn L. Parsley, J. Bueren, M. Grez, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

Christine Kinnon, Christof von Kalle, Michael Hubank, 2008, The Journal of clinical investigation.

Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.

Kathryn L. Parsley, P. Veys, A. Thrasher, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Kathryn L. Parsley, M. Grez, A. Thrasher, 2002, Human gene therapy.

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma

Kathryn L. Parsley, N. Sebire, A. Thrasher, 2012, Clinical and Translational Oncology.

High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter

Kathryn L. Parsley, M. Grez, A. Thrasher, 2002 .

Failure of SCID-X1 gene therapy in older patients.

Kathryn L. Parsley, C. von Kalle, A. Fischer, 2005, Blood.

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming.

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011, Blood.

Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Kathryn L. Parsley, P. Veys, S. Cooray, 2011, Science Translational Medicine.

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Christine Kinnon, Christof von Kalle, Dick de Ridder, 2007, The Journal of clinical investigation.

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

Kathryn L. Parsley, R. Levinsky, R. Ali, 2004, The Lancet.

Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency

Kathryn L. Parsley, S. Cooray, A. Thrasher, 2011, Science Translational Medicine.

necessary for normal immune synapse formation and T-cell priming Cytoskeletal remodeling mediated by WASp in dendritic cells is

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .

Immunodeficiency: Long-term persistence of a polyclonal t cell repertoire after gene therapy for X-linked severe combined immunodeficiency

Kathryn L. Parsley, S. Cooray, A. Thrasher, 2011 .

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Kathryn L. Parsley, R. Ali, J. Bainbridge, 2001, Gene Therapy.

Thymus transplantation for complete DiGeorge syndrome: European experience

Kathryn L. Parsley, N. Sebire, A. Worth, 2017, Journal of Allergy and Clinical Immunology.

Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.

Kathryn L. Parsley, A. Thrasher, M. Themis, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Update on treatment of human SCID-X1 by somatic gene therapy using a pseudotyped gammaretroviral vector

Kathryn L. Parsley, A. Thrasher, S. Howe, 2004 .

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming.

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011, Blood.

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .

Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming

Kathryn L. Parsley, S. Burns, A. Thrasher, 2011 .